Exact Mass: 452.2674936

Exact Mass Matches: 452.2674936

Found 500 metabolites which its exact mass value is equals to given mass value 452.2674936, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Repaglinide

2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid

C27H36N2O4 (452.2674936)

Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to cells of the pancreas to stimulate insulin release. Repaglinide induces an early insulin response to meals decreasing postprandial blood glucose levels. It should only be taken with meals and meal-time doses should be skipped with any skipped meal. Approximately one month of therapy is required before a decrease in fasting blood glucose is seen. Meglitnides may have a neutral effect on weight or cause a slight increase in weight. The average weight gain caused by meglitinides appears to be lower than that caused by sulfonylureas and insulin and appears to occur only in those naive to oral antidiabetic agents. Due to their mechanism of action, meglitinides may cause hypoglycemia although the risk is thought to be lower than that of sulfonylureas since their action is dependent on the presence of glucose. In addition to reducing postprandial and fasting blood glucose, meglitnides have been shown to decrease glycosylated hemoglobin (HbA1c) levels, which are reflective of the last 8-10 weeks of glucose control. Meglitinides appear to be more effective at lowering postprandial blood glucose than metformin, sulfonylureas and thiazolidinediones. Repaglinide is extensively metabolized in the liver and excreted in bile. Repaglinide metabolites do not possess appreciable hypoglycemic activity. Approximately 90\\% of a single orally administered dose is eliminated in feces and 8\\% in urine. C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98079 - Meglitinide Antidiabetic Agent A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins D007004 - Hypoglycemic Agents

Diphenoxylate

Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylic acid

C30H32N2O2 (452.24636519999996)

A meperidine congener used as an antidiarrheal, usually in combination with atropine. At high doses, it acts like morphine. Its unesterified metabolite difenoxin has similar properties and is used similarly. It has little or no analgesic activity. This medication is classified as a Schedule V under the Controlled Substances Act by the Food and Drug Administration (FDA) and the DEA in the United States when used in preparations. When diphenoxylate is used alone, it is classified as a Schedule II. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals

Bisbenzimide

2-(4-ethoxyphenyl)-5-[6-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1H-1,3-benzodiazole

C27H28N6O (452.2324478)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D020011 - Protective Agents > D011837 - Radiation-Protective Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D011838 - Radiation-Sensitizing Agents Bisbenzimide. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=23491-52-3 (retrieved 2024-08-14) (CAS RN: 23491-52-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Rhodojaponin I

Rhodojaponin I; Grayanotoxane-5,6,10,14,16-pentol, 2,3-epoxy-, 6,14-diacetate, (2beta,3beta,6beta,14R)-

C24H36O8 (452.2410056)

7-O-Dmethylcephaeline

7-O-Demethylcephaeline

C27H36N2O4 (452.2674936)

(14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide

16-(4,5-dimethyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-15-hydroxy-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,6-dien-9-one

C28H36O5 (452.2562606)

(14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide is found in fruits. (14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide is a constituent of Physalis peruviana (Cape gooseberry) Constituent of Physalis peruviana (Cape gooseberry). (14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide is found in fruits.

Tafluprost

1-Methylethyl (5Z)-7-((1R,2R, 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy -1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate

C25H34F2O5 (452.23741780000006)

Tafluprost is only found in individuals that have used or taken this drug. It is a prostaglandin analogue used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. Tafluprost was approved for use in the U.S. on February 10, 2012.Tafluprost is a prostaglandin F2a analogue. Specifically, Tafluprost is a prostanoid selective FP receptor agonist that is believed to reduce the intraocular pressure (IOP) by increasing the outflow of aqueous humor. Studies in animals and man suggest that the main mechanism of action is increased uveoscleral outflow. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EE - Prostaglandin analogues C78568 - Prostaglandin Analogue

1-nonadecanoyl-glycero-3-phosphate

[(2R)-2-hydroxy-3-(nonadecanoyloxy)propoxy]phosphonic acid

C22H45O7P (452.290275)

1-nonadecanoyl-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-nonadecanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule

LysoPA(19:0/0:0)

[2-hydroxy-3-(nonadecanoyloxy)propoxy]phosphonic acid

C22H45O7P (452.290275)

LysoPA(19:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(19:0/0:0), in particular, consists of one chain of nonadecylic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

LysoPA(i-19:0/0:0)

{2-hydroxy-3-[(17-methyloctadecanoyl)oxy]propoxy}phosphonic acid

C22H45O7P (452.290275)

LysoPA(i-19:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-19:0/0:0), in particular, consists of one chain of isononadecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

PA(10:0/8:0)

[(2R)-3-(decanoyloxy)-2-(octanoyloxy)propoxy]phosphonic acid

C21H41O8P (452.25389160000003)

PA(10:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/8:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(8:0/10:0)

[(2R)-2-(decanoyloxy)-3-(octanoyloxy)propoxy]phosphonic acid

C21H41O8P (452.25389160000003)

PA(8:0/10:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/10:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of capric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

Delapril

2-[N-(2,3-dihydro-1H-inden-2-yl)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanamido]acetic acid

C26H32N2O5 (452.2311102)

Tribendimidine

N-(4-{[(4-{[(4-{[1-(dimethylamino)ethylidene]amino}phenyl)imino]methyl}phenyl)methylidene]amino}phenyl)-N,N-dimethylethanimidamide

C28H32N6 (452.26883119999997)

Tribendimidine is an orally active, broad-spectrum anthelmintic agent, with particularly high activity against A. lumbricoides and N. americanus. Tribendimidine is also an L-type nicotinic acetylcholine receptor (nAChR) agonist[1][2][3].

1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea

N-Cycloheptyl-N-[(9H-fluoren-2-yl)methyl]-n-(2,4,6-trimethylphenyl)carbamimidate

C31H36N2O (452.2827486)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.277389)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C25H40O7 (452.277389)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.277389)

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.277389)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C25H40O7 (452.277389)

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.277389)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-3-(acetyloxy)-2-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.277389)

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

(2S)-3-(acetyloxy)-2-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.277389)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.277389)

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.277389)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.277389)

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.277389)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

10-O-Demethylcephaeline

(-)-10-Demethylcephaeline

C27H36N2O4 (452.2674936)

Glabcensin K

C24H36O8 (452.2410056)

20-Oxo-20,21-seco-tingen-21-oic acid

C28H36O5 (452.2562606)

Halisulfate 7

C25H40O5S (452.25963100000007)

Melissoidesin C

C24H36O8 (452.2410056)

Withametelin L

C28H36O5 (452.2562606)

Macrodasine B

C26H32N2O5 (452.2311102)

NSC349983

C28H36O5 (452.2562606)

Antiostatin B3

C26H36N4O3 (452.2787266)

Nimocinol

C28H36O5 (452.2562606)

Antiostatin B4

C26H36N4O3 (452.2787266)

15alpha,22beta-Dihydroxytingenone

C28H36O5 (452.2562606)

6alpha-O-Acetyl-7-deacetylnimocinol

(+)-6alpha-O-Acetyl-7-deacetylnimocinol

C28H36O5 (452.2562606)

Briarellin P

C25H40O7 (452.277389)

Melissoidesin K

C24H36O8 (452.2410056)

Argutin

C24H36O8 (452.2410056)

Sch 599473

C25H40O5S (452.25963100000007)

Celastranhydride

C28H36O5 (452.2562606)

caribaeorane

C27H36N2O4 (452.2674936)

Blazeispirol Y

C28H36O5 (452.2562606)

Withacoagulin

C28H36O5 (452.2562606)

Trichilenone acetate

C28H36O5 (452.2562606)

20,22beta-dihydroxytingenone

(-)-20,22beta-Dihydroxytingenone

C28H36O5 (452.2562606)

7-O-Demethylisocephaeline

(-)-7-O-Demethylisocephaeline

C27H36N2O4 (452.2674936)

A pyridoisoquinoline consisting of (1beta)-emetan substituted by hydroxy groups at positions 6 and 7 and methoxy groups at positions 10 and 11. It is isolated from Psychotria klugii and exhibits antileishmanial activity.

9-O-Demethylcephaeline

C27H36N2O4 (452.2674936)

Carbodenafil

C24H32N6O3 (452.2535762)

Noracetildenafil

Nor-Acetildenafil

C24H32N6O3 (452.2535762)

(E)-5-hydroxy-N-[3-[5-[3-[[(E)-5-hydroxy-3-methylpent-2-enoyl]amino]propyl]-3,6-dioxopiperazin-2-yl]propyl]-3-methylpent-2-enamide

C22H36N4O6 (452.2634716)

[(1S,2R,4aR,8aR)-1-acetyloxy-1,4a-dimethyl-6-oxo-7-propan-2-ylidene-2,3,4,5,8,8a-hexahydronaphthalen-2-yl] 3-acetyloxy-2-hydroxy-2-methylbutanoate

C24H36O8 (452.2410056)

2-Picenecarboxylic acid

(2R,4aS,6aS,12bR,14aS,14bR)-10,11-Dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,2,3,4,4a,5,6,6a,8,12b,13,14,14a,14b-tetradecahydro-2-picenecarboxylic acid

C28H36O5 (452.2562606)

7-hydroxy-6-oxopristimerol

C28H36O5 (452.2562606)

Laserpitinol

C25H40O7 (452.277389)

methyl-13S-hydroxy-14R,15-diacetoxy-1(10)-ent-halimen-18-oate

C25H40O7 (452.277389)

(20R,22R)-21,24-epoxy-5beta-hydroxy-1-oxowitha-2,9(11),25(27)-trienolide|withametelinol-A

C28H36O5 (452.2562606)

Benzoylramanone

C28H36O5 (452.2562606)

10-hidroxy 4,17-dihydro 17 beta-tchibangensine

C29H32N4O (452.25759819999996)

2alpha,3beta-dihydroxy-28-norurs-12,17,19(20),21(22)-tetraen-23-oic acid|2alpha,3beta-dihydroxy-28-norursa-12,17,19(20),21-tetraen-23-oic acid

C29H40O4 (452.29264400000005)

18-dihydrocinnamoyloxy-labda-7,13E-dien-15-oic acid

C29H40O4 (452.29264400000005)

C28H36O5

C28H36O5 (452.2562606)

19-(p-hydroxyhydrocinnamoyloxy)-ent-kauran-17-al|19--ent-kauran-17-al

C29H40O4 (452.29264400000005)

Toxin III (Helminthosporium carbonum)

C21H32N4O7 (452.22708819999997)

Nigakihemiacetal D

C24H36O8 (452.2410056)

proceranone

C28H36O5 (452.2562606)

grindelic acid 15-O-arabinoside

C25H40O7 (452.277389)

2??,5??,9??-Trihydroxy-10??,13??-diacetoxy-4??,20-epoxytaxa-11-ene

C24H36O8 (452.2410056)

14,15-Di-Ac,17-Me ester-13,14,15-Trihydroxy-7-labden-17-oic acid

C25H40O7 (452.277389)

Ecdysteron

C25H40O7 (452.277389)

(15R)-scutecyprol A|15beta-scutecyprol A|15R-scutecyprol A|clerodin hemiacetal

C24H36O8 (452.2410056)

(2beta,3beta,5alpha,6alpha)-2,3-bis(acetyloxy)-8,13-epoxy-6,9-dihydroxylabd-14-en-11-one|(3R,4aR,6S,6aS,8R,9S,10aS,10bS)-8,9-bis(acetyloxy)-3-ethenyldodecahydro-6,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one|excolabdone A

(2beta,3beta,5alpha,6alpha)-2,3-bis(acetyloxy)-8,13-epoxy-6,9-dihydroxylabd-14-en-11-one|(3R,4aR,6S,6aS,8R,9S,10aS,10bS)-8,9-bis(acetyloxy)-3-ethenyldodecahydro-6,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one|excolabdone A

C24H36O8 (452.2410056)

shimalactone B

C29H40O4 (452.29264400000005)

7alpha,12alpha,14beta,15beta-tetrahydroxy-3beta,19-diacetoxy-ent-kaur-16-ene|pharicinin D

C24H36O8 (452.2410056)

C29H40O4

C29H40O4 (452.29264400000005)

forrestin B

C24H36O8 (452.2410056)

C25H40O5S

C25H40O5S (452.25963100000007)

neomangicol A

C25H37ClO5 (452.23293820000004)

Mutamicin 2a

C18H36N4O9 (452.2482166)

seco-briarellin R

C24H36O8 (452.2410056)

Withanolide B

C29H40O4 (452.29264400000005)

6,7-dihydroxy-1,17-diacetoxymelcantholide

C24H36O8 (452.2410056)

withametelin B

C28H36O5 (452.2562606)

3beta,6alpha,11beta,15beta-tetrahydroxy-1alpha,7beta-diacetoxy-ent-kaur-16-ene|nervonin F

C24H36O8 (452.2410056)

DTXSID50978200

C24H36O8 (452.2410056)

1alpha,3beta,6alpha,15beta-tetrahydroxy-7beta,11beta-diacetoxy-ent-kaur-16-ene|nervonin I

C24H36O8 (452.2410056)

acnistin B

C28H36O5 (452.2562606)

C24H36O8

C24H36O8 (452.2410056)

C25H40O7

C25H40O7 (452.277389)

(1alpha,5alpha,6beta,7beta)-1,6-bis(acetyloxy)-8,13-epoxy-7,9-dihydroxylabd-14-en-11-one|(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10-bis(acetyloxy)-3-ethenyldodecahydro-5,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one|excolabdone B

(1alpha,5alpha,6beta,7beta)-1,6-bis(acetyloxy)-8,13-epoxy-7,9-dihydroxylabd-14-en-11-one|(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10-bis(acetyloxy)-3-ethenyldodecahydro-5,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one|excolabdone B

C24H36O8 (452.2410056)

Withametelin F|withmetelin F

C28H36O5 (452.2562606)

Withanolid O

C28H36O5 (452.2562606)

1,10-seco-withametelin B

C28H36O5 (452.2562606)

C26H32N2O5

C26H32N2O5 (452.2311102)

Delta16-withanolide

C28H36O5 (452.2562606)

27-Hydroxy-3-oxo-witha-1,4,24-trienolide

C29H40O4 (452.29264400000005)

Excelsine

C29H40O4 (452.29264400000005)

antidesmanin E|antidesmanin F|erythro-4-(2-(2-methoxy-4-((E)-3,3-dimethylpenta-1,4-dienyl)phenoxy)-1-hydroxy-3,3-dimethylpent-4-enyl)-2-methoxyphenol|threo-4-(2-(2-methoxy-4-((E)-3,3-dimethylpenta-1,4-dienyl)phenoxy)-1-hydroxy-3,3-dimethylpent-4-enyl)-2-methoxyphenol

antidesmanin E|antidesmanin F|erythro-4-(2-(2-methoxy-4-((E)-3,3-dimethylpenta-1,4-dienyl)phenoxy)-1-hydroxy-3,3-dimethylpent-4-enyl)-2-methoxyphenol|threo-4-(2-(2-methoxy-4-((E)-3,3-dimethylpenta-1,4-dienyl)phenoxy)-1-hydroxy-3,3-dimethylpent-4-enyl)-2-methoxyphenol

C28H36O5 (452.2562606)

(20R,22R)-17beta-hydroxy-1,12-dioxowitha-2,5,24-trien-26,22-olide|jaborosalactone 44

C28H36O5 (452.2562606)

9alpha,10beta-diacetoxy-2alpha,5alpha,14beta-trihydroxy-4,20-epoxy,11-taxene

C24H36O8 (452.2410056)

3-epi-14,15-dihydrocaryoptinol|3beta-hydroxy-14,15-dihydroclerodin|ajubractin E

C24H36O8 (452.2410056)

(7S,11S,12S)-1-methoxycystoketal

C29H40O4 (452.29264400000005)

pseudoferic acid A

C29H40O4 (452.29264400000005)

7beta,11alpha-diacetoxy-8,13-epoxy-6beta,9alpha-dihydroxylabd-14-ene-1-one|coleoforskolin

C24H36O8 (452.2410056)

dothideomycetone B

C25H40O7 (452.277389)

5,6-acetonylgrayanotoxin-I

C25H40O7 (452.277389)

(2S,3S,6R,7R,10R,11R,14S)-zonaquinone acetate

C29H40O4 (452.29264400000005)

(3R,4S,5R,6R,2R,3S)-3-O-(2,3-diacetoxy-2-methylbutyryl)cuauhtemone

C24H36O8 (452.2410056)

1-[11-(ferulyloxy)undecanoyl]glycerol|2,3-dihydroxypropyl 11-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}undecanoate

C24H36O8 (452.2410056)

eucalyptal D

C28H36O5 (452.2562606)

16-en-27-deoxywithaferin A

C28H36O5 (452.2562606)

spiralisone B

C28H36O5 (452.2562606)

24,25,26,27-tetra-norapotirucalla-(apoeupha)-6alpha-acetoxy-7alpha-hydroxy-1,14,20,22-tetraen-21,23-epoxy-3-one|6alpha-O-acetyl-7-deacetylnimocinol

C28H36O5 (452.2562606)

18-methylmalonyl-7alpha-hydroxy-methyltrineracetal

C25H40O7 (452.277389)

(22R)-4beta,27-dihydroxy-1-oxo-witha-2,5,16,24-tetraenolide|(4S,20S,22R)-4,27-dihydroxy-1-oxo-witha-2,5,16,24-tetraenolide

C28H36O5 (452.2562606)

MEGxp0_000412

C24H36O8 (452.2410056)

(20R,22R)-14,20-Dihydroxy-1-oxowitha-2,5,16,22-tetraenolide

C28H36O5 (452.2562606)

withanolide U

C28H36O5 (452.2562606)

Vepinin

C28H36O5 (452.2562606)

norselic acid A

3-oxo-24R-hydroxy-poriferast-1,4,6,26-tetraen-18-oic acid

C29H40O4 (452.29264400000005)

8|A-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate

C29H40O4 (452.29264400000005)

L-MeIle-L-Acm-L-Glu

C22H36N4O6 (452.2634716)

3,22beta-dihydroxy-24,29-dinor-1(10),3,5-friedelatriene-2,7,21-trione

C28H36O5 (452.2562606)

salaquinone B

C28H36O5 (452.2562606)

Natalic acid

C29H40O4 (452.29264400000005)

Uprolide F diacetate

C24H36O8 (452.2410056)

coagulin F

C28H36O5 (452.2562606)

lettowinone|methyl [3-(3,7-dimethylocta.2,6-dienyl)-6-methyl-5-(3-methylbut-2-enyl)-1,4-dioxo-1,5,8,8a-tetrahydro-4H-naphthalen-4a-yl]acetate

C29H40O4 (452.29264400000005)

6alpha,8alpha,23,14,15-erythro-pentahydroxy-labd-13(21),17-dien-16,19-olide|6alpha,8alpha,23,14,15-threo-pentahydroxy-labd-13(21),17-dien-16,19-olide

C25H40O7 (452.277389)

Forskolin J

C24H36O8 (452.2410056)

2.3-dihydroxy-24-nor-friedelatetraen-(1.3.5(10).7)-oic acid-(29)|2.3-Dihydroxy-24-nor-friedelatetraen-(1.3.5(10).7)-saeure-(29)|Dihydrocelastrol

C29H40O4 (452.29264400000005)

(22R,Z)-16beta,27-dihydroxy-1-oxo-witha-2,5,17(20),24-tetraenolide

C28H36O5 (452.2562606)

3,7,9-trihydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O5 (452.2562606)

13S-labda-8(17),14-diene-13-(cis-hydroxycinnamoxy)-19-ol

C29H40O4 (452.29264400000005)

(20R,22R)-14,20-Dihydroxy-1-oxowitha-2,4,6,24-tetraenolide|14alpha,20alphaF-dihydroxy-1-oxo-22R-witha-2,4,6,24-tetraenolide

C28H36O5 (452.2562606)

6beta,7beta,11beta,14beta,15beta-pentahydroxy-20-isoamoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin F

C25H40O7 (452.277389)

16-en-27-deoxywithaferin A|27-deoxy-Delta(16)-withaferin A|5beta,6beta-epoxy-4beta-hydroxy-1-oxo-witha-2,16,24-trienolide

C28H36O5 (452.2562606)

calotropone

C28H36O5 (452.2562606)

C23H36N2O7

C23H36N2O7 (452.2522386)

17-hydroxy-19-(p-hydroxyhydrocinnamoyloxy)-iso-kaurene|17-hydroxy-19--iso-kaurene

C29H40O4 (452.29264400000005)

Tomentin

C25H40O7 (452.277389)

sulfircin

C25H40O5S (452.25963100000007)

6-oxo-20-hydroxy-20-epi-tingenol

C28H36O5 (452.2562606)

1-(18-hydroxyoleoyl)-sn-glycrol 3-phosphate

C21H41O8P (452.25389160000003)

Triptohypol C

(2R,4aS,6aS,12bS,14aS,14bR)-10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,3,4,4a,5,6,6a,8,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid

C29H40O4 (452.29264400000005)

Triptohypol C is a pentacyclic triterpenoid with formula C29H40O4, originally isolated from the root bark of Tripterygium regelii. It has a role as a plant metabolite and an apoptosis inducer. It is a pentacyclic triterpenoid, a monocarboxylic acid and a member of benzenediols. Dihydrocelastrol is a natural product found in Tripterygium hypoglaucum and Tripterygium wilfordii with data available. A pentacyclic triterpenoid with formula C29H40O4, originally isolated from the root bark of Tripterygium regelii. Triptohypol C, a Tripterin (HY-13067) derivative, is a potent Nur77-targeting anti-inflammatory agent with an Kd value of 0.87 μM. Triptohypol C inhibits inflammatory response by promoting the interactions of Nur77 with TRAF2 and p62/SQSTM1[1].

Glabralide C

C29H40O4 (452.29264400000005)

Repaglinide

C27H36N2O4 (452.2674936)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98079 - Meglitinide Antidiabetic Agent A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 2189 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3349

Diphenoxylate

Diphenoxylate(to be removed)

C30H32N2O2 (452.24636519999996)

A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals

C28H36O5_2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,8,12b,13,14,14a,14b-tetradecahydro-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-, (2R,4aS,6aS,12bR,14aS,14bR)

NCGC00180745-02_C28H36O5_2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,8,12b,13,14,14a,14b-tetradecahydro-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-, (2R,4aS,6aS,12bR,14aS,14bR)-

C28H36O5 (452.2562606)

C24H36O8_Butanoic acid, 3-(acetyloxy)-2-hydroxy-2-methyl-, (1S,2R,4aR,8aR)-1-(acetyloxy)decahydro-1,4a-dimethyl-7-(1-methylethylidene)-6-oxo-2-naphthalenyl ester

NCGC00347519-02_C24H36O8_Butanoic acid, 3-(acetyloxy)-2-hydroxy-2-methyl-, (1S,2R,4aR,8aR)-1-(acetyloxy)decahydro-1,4a-dimethyl-7-(1-methylethylidene)-6-oxo-2-naphthalenyl ester

C24H36O8 (452.2410056)

(2R,4aS,6aR,6aS,14aS,14bR)-10,11-dihydroxy-2,4a,6a,6a,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid

C28H36O5 (452.2562606)

18,19-dihydrousambarine

C30H36N4 (452.2939816)

Dihydrocelastrol

C29H40O4 (452.29264400000005)

[(1S,2R,4aR,8aR)-1-acetyloxy-1,4a-dimethyl-6-oxo-7-propan-2-ylidene-2,3,4,5,8,8a-hexahydronaphthalen-2-yl] 3-acetyloxy-2-hydroxy-2-methylbutanoate_major

C24H36O8 (452.2410056)

Ala His Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747046)

Ala His Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747046)

Ala His Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747046)

Ala His Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747046)

Ala Ile His Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747046)

Ala Ile His Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747046)

Ala Ile Ile His

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747046)

Ala Ile Leu His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747046)

Ala Ile Ser Tyr

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O7 (452.22708819999997)

Ala Ile Tyr Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanoic acid

C21H32N4O7 (452.22708819999997)

Ala Leu His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747046)

Ala Leu His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747046)

Ala Leu Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747046)

Ala Leu Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747046)

Ala Leu Ser Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O7 (452.22708819999997)

Ala Leu Tyr Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanoic acid

C21H32N4O7 (452.22708819999997)

Ala Ser Ile Tyr

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O7 (452.22708819999997)

Ala Ser Leu Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O7 (452.22708819999997)

Ala Ser Tyr Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanoic acid

C21H32N4O7 (452.22708819999997)

Ala Ser Tyr Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanoic acid

C21H32N4O7 (452.22708819999997)

Ala Thr Val Tyr

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O7 (452.22708819999997)

Ala Thr Tyr Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoic acid

C21H32N4O7 (452.22708819999997)

Ala Val Thr Tyr

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O7 (452.22708819999997)

Ala Val Tyr Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanoic acid

C21H32N4O7 (452.22708819999997)

Ala Tyr Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H32N4O7 (452.22708819999997)

Ala Tyr Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H32N4O7 (452.22708819999997)

Ala Tyr Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H32N4O7 (452.22708819999997)

Ala Tyr Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H32N4O7 (452.22708819999997)

Ala Tyr Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H32N4O7 (452.22708819999997)

Ala Tyr Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H32N4O7 (452.22708819999997)

Phe Ile Ser Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C21H32N4O7 (452.22708819999997)

Phe Leu Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C21H32N4O7 (452.22708819999997)

Phe Ser Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C21H32N4O7 (452.22708819999997)

Phe Ser Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C21H32N4O7 (452.22708819999997)

Phe Ser Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C21H32N4O7 (452.22708819999997)

Phe Ser Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C21H32N4O7 (452.22708819999997)

Phe Ser Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C21H32N4O7 (452.22708819999997)

Phe Ser Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C21H32N4O7 (452.22708819999997)

Phe Thr Ser Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-methylbutanoic acid

C21H32N4O7 (452.22708819999997)

Phe Thr Val Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxybutanamido]-3-methylbutanamido]-3-hydroxypropanoic acid

C21H32N4O7 (452.22708819999997)

Phe Val Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C21H32N4O7 (452.22708819999997)

Phe Val Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C21H32N4O7 (452.22708819999997)

19-Norandrosterone glucuronide

C24H36O8 (452.2410056)

b-D-Glucopyranosiduronic acid, (3a,5b)-17-oxoestran-3-yl

C24H36O8 (452.2410056)

b-D-Glucopyranosiduronic acid, (3b,5a)-17-oxoestran-3-yl

C24H36O8 (452.2410056)

b-D-Glucopyranosiduronic acid, (3b,5b)-17-oxoestran-3-yl

C24H36O8 (452.2410056)

Gly Ile Thr Tyr

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O7 (452.22708819999997)

Gly Ile Tyr Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanoic acid

C21H32N4O7 (452.22708819999997)

Gly Leu Thr Tyr

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O7 (452.22708819999997)

Gly Leu Tyr Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanoic acid

C21H32N4O7 (452.22708819999997)

Gly Thr Ile Tyr

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O7 (452.22708819999997)

Gly Thr Leu Tyr

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H32N4O7 (452.22708819999997)

Gly Thr Tyr Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanoic acid

C21H32N4O7 (452.22708819999997)

Gly Thr Tyr Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanoic acid

C21H32N4O7 (452.22708819999997)

Gly Tyr Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C21H32N4O7 (452.22708819999997)

Gly Tyr Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C21H32N4O7 (452.22708819999997)

Gly Tyr Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C21H32N4O7 (452.22708819999997)

Gly Tyr Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C21H32N4O7 (452.22708819999997)

His Ala Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747046)

His Ala Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747046)

His Ala Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747046)

His Ala Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747046)

His Ile Ala Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747046)

His Ile Ala Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747046)

His Ile Ile Ala

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylpentanamido]propanoic acid

C21H36N6O5 (452.2747046)

His Ile Leu Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-methylpentanamido]propanoic acid

C21H36N6O5 (452.2747046)

His Ile Pro Ser

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid